VTIV Inventiv Health (MM)

inVentiv Clinical, a division of inVentiv Health (Nasdaq:VTIV), today announced a substantive expansion of the inVentiv Clinical Global Alliance with the additions of Protech Pharmaservices Corporation (PPC), Ecron Acunova and RDDA. These partners, along with ActivaCRO, will broaden inVentiv Clinical Solutions' clinical research capabilities in Latin America, Asia, Europe and Africa and provide CRO service coverage in more than 50 countries.

PPC (www.ppccro.com) is inVentiv Clinical's Asia Pacific partner with its headquarters located in Taiwan. With vast clinical experience across Asia, PPC is renowned in major countries of clinical interest such as Taiwan, Japan, China, Korea, Hong Kong, Singapore, Malaysia and Australia. PPC is dedicated to serving the pharmaceutical, biotechnology, generic drug and medical device industries with a full spectrum of drug development solutions, including phase I - IV clinical study management, bioavailability / bioequivalence studies, central laboratory, data management and statistical analysis.

Ecron Acunova (www.ecronacunova.com ), inVentiv Clinical's partner for Europe, has its European headquarters in Frankfurt, Germany and operations across Europe, Asia and the Americas. With 23 years of clinical expertise, Ecron Acunova provides end-to-end services for phase I - IV clinical research, including clinical trial management, clinical data management, PK/PD services and central lab for pharmaceutical, biotech, nutritional, medical diagnostic and device sponsors. Ecron Acunova has existing relationships with several members of the Global Alliance, including an ongoing collaboration with Essential CRO, which was acquired by inVentiv Clinical early 2010, and a prior partnership with PPC in Taiwan.

RDDA (www.rddacro.co.za), inVentiv Clinical's African partner, is a contract research organization based in Pretoria, South Africa and was founded by three partners with a vision to provide the international pharmaceutical industry with expert services in clinical trials in Africa. RDDA provides regulatory, project management and monitoring support across Africa including South Africa, Namibia, Botswana, Zambia, Kenya, Mozambique and Zimbabwe.

"We are very pleased to welcome PPC, Ecron Acunova and RDDA to the inVentiv Clinical Global Alliance, which already includes ActivaCRO in Latin America (http://www.activa-cro.com). The expansion of our alliance is consistent with our mission to help clients accelerate quality clinical research in a cost-effective manner," comments Michael Hlinak, President and CEO of inVentiv Clinical. "By forging alliances with these first-class partners, we are better positioned to provide our clients the unique, flexible solutions and unmatched quality they have come to expect from inVentiv Clinical, but on a global scale where it is needed today. Furthermore, this Global Alliance represents significant operational integration and access to rapidly developing clinical research markets."

"We are pleased to offer our delivery capabilities in Western and Eastern European countries, including Ukraine and Russia, and to the partners in the inVentiv Clinical network," said D A Prasanna, Founder and Vice Chairman of Ecron Acunova. 

"PPC is glad to be part of a network that represents global integration and world-class solutions," said Johnny Cheng, PPC Chief Operations Officer.

"We at RDDA are indeed very proud to be part of this prominent partnership which now covers the entire world.  It is a great achievement for RDDA to be the sole and exclusive partner in Southern Africa.  Apart from our in-depth therapeutic knowledge in oncology, haematology, HIV/AIDS, cardiovascular disorders, etc. where we have more than 10 years experience, we are committed through our partnership to widen our expertise to be a real and effective asset to the group," Dr. Patrice Bassompierre, CEO of RDDA, said.

"We are delighted to welcome such recognized organizations to the partnership. With their incorporation, the inVentiv Clinical Global Alliance is presently in a position to cover the world´s major research locations," said Mario Boskis, President and Chief Operating Officer of ActivaCRO.

To learn more about the inVentiv Clinical Global Alliance, please contact Fernando Martinez at fmartinez@inventivclinical.com.

About inVentiv Clinical

inVentiv Clinical Solutions is the premier provider of unique clinical outsourcing solutions, allowing the greatest control and flexibility through unmatched access to high quality clinical resources. As a strategic partner, inVentiv Clinical Solutions provides clinical trial management and monitoring, data management and biostatistics solutions, medical writing, regulatory consulting and liaison services and patient and investigator recruitment. These services are complemented by traditional clinical staffing capabilities through our industry leading staffing divisions, MedFocus and Smith Hanley Consulting Group. For more information, visit www.inventivclinical.com.

About inVentiv Health

inVentiv Health (Nasdaq:VTIV) is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payer companies, including the top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.

The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942

CONTACT:  inVentiv Health, Inc.
          Investors:
          David Bassin, CFO
            (732) 537-4804
            investor@inventivhealth.com
          Media:
          Marcia Frederick
            (614) 543-6281
            mfrederick@inventivhealth.com